3.54
1.14%
0.04
Handel nachbörslich:
3.65
0.11
+3.11%
Schlusskurs vom Vortag:
$3.50
Offen:
$3.54
24-Stunden-Volumen:
104.82K
Relative Volume:
2.25
Marktkapitalisierung:
$38.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-34.36M
KGV:
-0.099
EPS:
-35.74
Netto-Cashflow:
$-25.81M
1W Leistung:
-9.92%
1M Leistung:
-18.78%
6M Leistung:
-38.33%
1J Leistung:
+24.21%
Calcimedica Inc Stock (CALC) Company Profile
Firmenname
Calcimedica Inc
Sektor
Branche
Telefon
858-952-5500
Adresse
505 COAST BOULEVARD SOUTH, LA JOLLA
Calcimedica Inc Aktie (CALC) Neueste Nachrichten
H.C. Wainwright cuts CalciMedica stock target to $16, keeps Buy rating - Investing.com Canada
Graybug Vision Suspends Stock Offering Amid Proposed Public Offering of CalciMedica - Defense World
Calcimedica director Robert Wilson acquires $199,998 in stock - Investing.com India
CalciMedica's chief business officer Eric Roberts acquires $199,998 in stock By Investing.com - Investing.com Australia
Calcimedica director Robert Wilson acquires $199,998 in stock By Investing.com - Investing.com Australia
Director Robert Wilson Acquires 53,333 Shares of CalciMedica Inc (CALC) - GuruFocus.com
CalciMedica CEO Rachel Leheny acquires $75,000 in common stock - Investing.com
CalciMedica's chief business officer Eric Roberts acquires $199,998 in stock - Investing.com
CalciMedica CEO Rachel Leheny acquires $75,000 in common stock By Investing.com - Investing.com UK
CalciMedica announces proposed public offering of common stock - MSN
CalciMedica Announces Pricing of Public Offering of Common Stock - StockTitan
CalciMedica launches public stock offering - Investing.com
CalciMedica launches public stock offering By Investing.com - Investing.com UK
CalciMedica Announces Proposed Public Offering of Common Stock - StockTitan
CalciMedica, Inc. (NASDAQ:CALC) Sees Significant Decline in Short Interest - MarketBeat
CalciMedica’s Promising Phase 2b Trial Results for Auxora - TipRanks
CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting - PR Newswire
CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) - Citizentribune
Standard BioTools And 2 Other Penny Stocks Executives Are Buying - MSN
CalciMedica (NASDAQ:CALC) Stock Price Up 1% – Here’s What Happened - Defense World
CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting - StockTitan
Scientech Research LLC Buys New Position in Grand Canyon Education, Inc. (NASDAQ:LOPE) - Defense World
Kenvue Inc. (NYSE:KVUE) Shares Bought by Brandes Investment Partners LP - Defense World
Regal Investment Advisors LLC Has $7.19 Million Holdings in AT&T Inc. (NYSE:T) - Defense World
LandBridge (NYSE:LB) and Texas Pacific Land (NYSE:TPL) Financial Comparison - Defense World
Baozun Inc. (NASDAQ:BZUN) Short Interest Update - Defense World
CalciMedica, Inc. (NASDAQ:CALC) Short Interest Up 5.1% in September - Defense World
Likewise Group (LON:LIKE) Stock Price Up 3.1% Following Dividend Announcement - Defense World
Senator Investment Group LP Acquires New Position in CleanSpark, Inc. (NASDAQ:CLSK) - Defense World
Evergreen Capital Management LLC Takes Position in IAC Inc. (NASDAQ:IAC) - Defense World
Caxton Associates LP Sells 4,741 Shares of Verizon Communications Inc. (NYSE:VZ) - Defense World
Regencell Bioscience (NASDAQ:RGC) Stock Quotes, Forecast and News Summary - Benzinga
Acute Pancreatitis Market Business Insights, Key Trend Analysis - Economica
CalciMedica (NASDAQ:CALC) Shares Down 2% - Defense World
CalciMedica (NASDAQ:CALC) Trading Down 2% - Defense World
Allegiant Travel (NASDAQ:ALGT) Issues Q3 2024 Earnings Guidance - MarketBeat
Milan stock market opens weak, luxury retraces, cues on doValue, down Lottomatica after Abb - Marketscreener.com
Poseida Therapeutics Garners FDA RMAT Designation for Allogeneic CAR-T P-BCMA-ALLO1 in R/R Multiple Myeloma - CGTLive™
Allete takeover will get a recommendation from Minnesota PUC's ALJ by July 15 - Seeking Alpha
CAH Stock Sees Decline of Approximately -1.71% in Last Five Days - Knox Daily
Will CARPO Data Propel CalciMedica Stock? - RTTNews
Cardinal Health Inc. stock rises Monday, still underperforms market - MarketWatch
Insight Health Systems of Flint plans to purchase ProMedica Coldwater Regional Hospital - Coldwater Daily Reporter
Forsta AP Fonden Acquires 11,900 Shares of Allegion plc (NYSE:ALLE) - Defense World
11,237 Shares in Allegion plc (NYSE:ALLE) Acquired by Acadian Asset Management LLC - Defense World
Calumet Specialty Products Partners (NASDAQ:CLMT) Shares Gap Down to $16.58 - Defense World
CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Kilgore News Herald
CalciMedica And 2 Other Penny Stocks Insiders Are Buying - MSN
CalciMedica Inc [CALC] Shares Jump Approximately 60.20% Over the Year - Knox Daily
CalciMedica, Inc. (NASDAQ:CALC) Short Interest Down 6.5% in August - Defense World
CalciMedica CEO acquires $4,189 in stock at $4.20-$4.27 range - Investing.com
Finanzdaten der Calcimedica Inc-Aktie (CALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):